These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24131416)

  • 1. Antipsychotic options for delirium-related agitation--a multidisciplinary practitioner survey.
    Passmore MJ; Virani A; Hendel K
    Issues Ment Health Nurs; 2013 Nov; 34(11):836-8. PubMed ID: 24131416
    [No Abstract]   [Full Text] [Related]  

  • 2. Responsibility for patients after the handoff.
    Macauley R
    Virtual Mentor; 2012 May; 14(5):373-7. PubMed ID: 23351201
    [No Abstract]   [Full Text] [Related]  

  • 3. Don't use antipsychotics routinely to treat agitation and aggression in people with dementia.
    Corbett A; Burns A; Ballard C
    BMJ; 2014 Nov; 349():g6420. PubMed ID: 25368388
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhaled Loxapine for ECT Pretreatment for Agitation.
    Jaffe R; Siniscalchi M; Cruz-Luna N; Cosgrove D
    J ECT; 2016 Jun; 32(2):146. PubMed ID: 26439438
    [No Abstract]   [Full Text] [Related]  

  • 5. Inefficacy of antipsychotics in treatment of delirium and agitation in two cases of bickerstaff brainstem encephalitis.
    Alam A; Puri NV
    J Neuropsychiatry Clin Neurosci; 2014 Apr; 26(2):176-8. PubMed ID: 24763765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged delirium managed with risperidone.
    Bourgeois JA; Hilty DM
    Psychosomatics; 2005; 46(1):90-1. PubMed ID: 15765831
    [No Abstract]   [Full Text] [Related]  

  • 7. Old drug in new package promises to calm the agitated.
    Morrow T
    Manag Care; 2014 Apr; 23(4):50-1. PubMed ID: 24864536
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of intravenous medication dosage.
    Fernandez F; Adams F
    J Clin Psychopharmacol; 1986 Apr; 6(2):127-8. PubMed ID: 2871056
    [No Abstract]   [Full Text] [Related]  

  • 9. Pain, agitation, delirium, and neuromuscular blockade: a review of basic pharmacology, assessment, and monitoring.
    Altshuler J; Spoelhof B
    Crit Care Nurs Q; 2013; 36(4):356-69. PubMed ID: 24002426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of loxapine for inhalation in the treatment of agitation in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial.
    Allen MH; Feifel D; Lesem MD; Zimbroff DL; Ross R; Munzar P; Spyker DA; Cassella JV
    J Clin Psychiatry; 2011 Oct; 72(10):1313-21. PubMed ID: 21294997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New medical approach to out-of-hospital treatment of psychomotor agitation in psychiatric patients: a report of 14 cases].
    Cester-Martínez A; Cortés-Ramas JA; Borraz-Clares D; Pellicer-Gayarre M
    Emergencias; 2017 Jun; 29(3):182-184. PubMed ID: 28825239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Safeguarding the prescription of antipsychotics in the paediatric population: A French multicentric study in a treatment naïve population].
    Menard ML; Askénazy F; Auby P; Bonnot O; Cohen D
    Encephale; 2013 Oct; 39(5):313-4. PubMed ID: 23809174
    [No Abstract]   [Full Text] [Related]  

  • 13. The pain, agitation, and delirium care bundle: synergistic benefits of implementing the 2013 Pain, Agitation, and Delirium Guidelines in an integrated and interdisciplinary fashion.
    Barr J; Pandharipande PP
    Crit Care Med; 2013 Sep; 41(9 Suppl 1):S99-115. PubMed ID: 23989099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of a protocol for integrated management of pain, agitation, and delirium can improve clinical outcomes in the intensive care unit: a randomized clinical trial.
    Mansouri P; Javadpour S; Zand F; Ghodsbin F; Sabetian G; Masjedi M; Tabatabaee HR
    J Crit Care; 2013 Dec; 28(6):918-22. PubMed ID: 24011845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled loxapine for agitation in patients with personality disorder: an initial approach.
    Patrizi B; Navarro-Haro MV; Gasol M
    Eur Neuropsychopharmacol; 2019 Jan; 29(1):122-126. PubMed ID: 30497838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Now take a deep breath: inhaled loxapine for the treatment of acute agitation.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2012 Jan; 50(1):16-8. PubMed ID: 22229963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiprofessional care for delirium patients in intensive care: integrative review.
    Souza TL; Azzolin KO; Fernandes VR
    Rev Gaucha Enferm; 2018 Aug; 39():e20170157. PubMed ID: 30088606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled loxapine: a new treatment for agitation in schizophrenia or bipolar disorder.
    Owen RT
    Drugs Today (Barc); 2013 Mar; 49(3):195-201. PubMed ID: 23527323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of Inhaled Loxapine in Dual-Diagnosis Patients: A Case Series.
    Roncero C; Ros-Cucurull E; Grau-López L; Fadeuilhe C; Casas M
    Clin Neuropharmacol; 2016; 39(4):206-9. PubMed ID: 27015036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled loxapine (Adasuve) for acute agitation.
    Med Lett Drugs Ther; 2014 Apr; 56(1440):31-2. PubMed ID: 24736249
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.